{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:13:29Z","timestamp":1788790409561,"version":"build-2803163510"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sleep-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.sleep.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T02:01:40Z","timestamp":1486778500000},"page":"125-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3322-4943","authenticated-orcid":false,"given":"Marta","family":"Kollb-Sielecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Demolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Emmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Markey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Salmonson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2017.01.002_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/014107680209500503","article-title":"The hypocretin\/orexin system","volume":"95","author":"Ebrahim","year":"2002","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.sleep.2017.01.002_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","article-title":"BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology","volume":"320","author":"Ligneau","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.sleep.2017.01.002_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-\/- mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.sleep.2017.01.002_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/bph.12149","article-title":"Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist\/antagonist compared with Modafinil","volume":"169","author":"Uguen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2017.01.002_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2017.01.002_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/oby.2003.156","article-title":"Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity","volume":"11","author":"Kok","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.sleep.2017.01.002_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1097-4679(198901)45:1<51::AID-JCLP2270450107>3.0.CO;2-H","article-title":"Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients","volume":"45","author":"Mosko","year":"1989","journal-title":"J\u00a0Clin Psychol"},{"key":"10.1016\/j.sleep.2017.01.002_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1389-9457(03)00059-5","article-title":"Sleep disorders and depressive feelings: a global survey with the Beck depression scale","volume":"4","author":"Vandeputte","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2017.01.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(16)30333-7","article-title":"Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a\u00a0randomised, double-blind, placebo-controlled trial","author":"Szakacs","year":"2017","journal-title":"Lancet Neurol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945717300102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945717300102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T07:04:43Z","timestamp":1531724683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945717300102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":9,"alternative-id":["S1389945717300102"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2017.01.002","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}